These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7750102)

  • 1. Expression of the p53 gene and presence of serum autoantibodies in ovarian cancer: correlation with differentiation.
    Green JA; Robertson LJ; Campbell IR; Jenkins J
    Cancer Detect Prev; 1995; 19(2):151-5. PubMed ID: 7750102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival.
    Angelopoulou K; Rosen B; Stratis M; Yu H; Solomou M; Diamandis EP
    Cancer; 1996 Nov; 78(10):2146-52. PubMed ID: 8918407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral p53 antibody response is a prognostic parameter in ovarian cancer.
    Mayerhofer K; Tempfer C; Kucera E; Hefler L; Zeisler H; Kainz C; Zeillinger R; Sliutz G
    Anticancer Res; 1999; 19(1B):875-8. PubMed ID: 10216509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation.
    Leffers N; Lambeck AJ; de Graeff P; Bijlsma AY; Daemen T; van der Zee AG; Nijman HW
    Gynecol Oncol; 2008 Sep; 110(3):365-73. PubMed ID: 18571704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass.
    Vogl FD; Frey M; Kreienberg R; Runnebaum IB
    Br J Cancer; 2000 Nov; 83(10):1338-43. PubMed ID: 11044359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry.
    Henriksen R; Strang P; Wilander E; Bäckström T; Tribukait B; Oberg K
    Gynecol Oncol; 1994 Jun; 53(3):301-6. PubMed ID: 8206402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer.
    Gadducci A; Ferdeghini M; Buttitta F; Cosio S; Fanucchi A; Annicchiarico C; Gagetti O; Bevilacqua G; Genazzani AR
    Gynecol Oncol; 1999 Jan; 72(1):76-81. PubMed ID: 9889034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of p53 autoantibodies in the serum of patients with breast cancer.
    Willsher PC; Pinder SE; Robertson L; Nicholson RI; Ellis IO; Bell JA; Blamey RW; Green JA; Robertson JF
    Anticancer Res; 1996; 16(2):927-30. PubMed ID: 8687153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [P53-status in primary ovarian carcinomas, ovarian metastases of neoplasms in other sites and benign ovarian tumors: predictive value in comparison to histopathological parameters].
    Casper F; Weikel W; Schaffrath M; Kuner RP; Hoffmann G; Pollow B; Pollow K
    Zentralbl Gynakol; 2000; 122(3):153-9. PubMed ID: 10756599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
    Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
    Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
    Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE
    Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinum-treated patients.
    Alvarez AA; Axelrod JR; Whitaker RS; Isner PD; Bentley RC; Dodge RK; Rodriguez GC
    Gynecol Oncol; 2001 Aug; 82(2):273-8. PubMed ID: 11531279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas.
    Høgdall EV; Christensen L; Høgdall CK; Frederiksen K; Gayther S; Blaakaer J; Jacobs IJ; Kjaer SK
    APMIS; 2008 May; 116(5):400-9. PubMed ID: 18452430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study.
    Lenner P; Wiklund F; Emdin SO; Arnerlöv C; Eklund C; Hallmans G; Zentgraf H; Dillner J
    Br J Cancer; 1999 Feb; 79(5-6):927-32. PubMed ID: 10070892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer.
    Goodell V; Salazar LG; Urban N; Drescher CW; Gray H; Swensen RE; McIntosh MW; Disis ML
    J Clin Oncol; 2006 Feb; 24(5):762-8. PubMed ID: 16391298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
    Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH
    Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of serum autoantibodies to tumor suppressor gene p53 with a new enzyme-linked immunosorbent assay in patients with ovarian cancer.
    Marx D; Frey M; Zentgraf H; Adelssen G; Schauer A; Kuhn W; Meden H
    Cancer Detect Prev; 2001; 25(2):117-22. PubMed ID: 11341346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [C-erbB-2 protein in ovarian epithelial cancer: correlation between expression in tumor tissue and blood levels].
    Felip E; Encabo G; Vidal MT; Vera R; del Campo JM; Rubio D
    Med Clin (Barc); 1995 Jun; 105(1):5-8. PubMed ID: 7637419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.